Clinical Trial: A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults >= 50 Years of Age

U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07365826) titled 'A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults >= 50 Years of Age' on Jan. 22.

Brief Summary: This is a Phase 3, randomized, double-blind study to evaluate the safety and immunogenicity of VAX-31 and seasonal influenza vaccine in pneumococcal-naive adults >= 50 years when the two vaccines are administered at the same visit or separately.

Study Start Date: Jan. 12

Study Type: INTERVENTIONAL

Condition: Pneumococcal Vaccines

Intervention: BIOLOGICAL: 31-valent pneumococcal conjugate vaccine

0.5 mL of VAX-31 will be administered into the deltoid muscle

BIOLOGI...